CA1273576A — Topical treatment for diseased skin disorders
Assigned to Individual · Expires 1990-09-04 · 36y expired
What this patent protects
ABSTRACT A unique combination of chemical substances and a method of their use is proposed, each chemical substance having individual merit as medicinal agents when used in solution or other pharmaceutical forms has been discovered to be effective in combination in th…
USPTO Abstract
ABSTRACT A unique combination of chemical substances and a method of their use is proposed, each chemical substance having individual merit as medicinal agents when used in solution or other pharmaceutical forms has been discovered to be effective in combination in the topical treatment of several diseased skin conditions including Herpes Simplex, acne, psoriasis, and dermatitis. The combination comprises a mixture of: (a) at lease one antiseptic and/or anesthetic compound which is (i) a terpene (e.g. menthol and eucalyptol, both being oxygenated terpenes); (ii) a phenolic compound (e.g. thymol); or, (iii) an alcohol; (b) a quaternary ammonium antiseptic compound; and, (c) an antiseptic compound containing iodine salts thereof and/or complexes thereof dissolved in an organic skin penetrating solvent.
Drugs covered by this patent
- Azelex (AZELAIC ACID) · Leo Pharma As
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.